JP2024523394A5 - - Google Patents
Info
- Publication number
- JP2024523394A5 JP2024523394A5 JP2023577861A JP2023577861A JP2024523394A5 JP 2024523394 A5 JP2024523394 A5 JP 2024523394A5 JP 2023577861 A JP2023577861 A JP 2023577861A JP 2023577861 A JP2023577861 A JP 2023577861A JP 2024523394 A5 JP2024523394 A5 JP 2024523394A5
- Authority
- JP
- Japan
- Prior art keywords
- item
- target gene
- krab
- complex
- dnmt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163211791P | 2021-06-17 | 2021-06-17 | |
| US63/211,791 | 2021-06-17 | ||
| PCT/US2022/033797 WO2022266324A1 (en) | 2021-06-17 | 2022-06-16 | Systems and methods for regulating aberrant gene expressions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024523394A JP2024523394A (ja) | 2024-06-28 |
| JP2024523394A5 true JP2024523394A5 (https=) | 2025-06-13 |
Family
ID=84525869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023577861A Pending JP2024523394A (ja) | 2021-06-17 | 2022-06-16 | 異常な遺伝子発現を調節するためのシステムおよび方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240216482A1 (https=) |
| EP (1) | EP4355357A4 (https=) |
| JP (1) | JP2024523394A (https=) |
| KR (1) | KR20240032038A (https=) |
| CN (1) | CN117940150A (https=) |
| AU (1) | AU2022293494A1 (https=) |
| CA (1) | CA3221874A1 (https=) |
| GB (1) | GB2624791A (https=) |
| IL (1) | IL309174A (https=) |
| MX (1) | MX2023014750A (https=) |
| WO (1) | WO2022266324A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3192654A1 (en) | 2020-09-01 | 2022-03-10 | The Board Of Trustees Of The Leland Stanford Junior Unversity | Synthetic miniature crispr-cas (casmini) system for eukaryotic genome engineering |
| CN119137268A (zh) | 2022-03-01 | 2024-12-13 | 埃皮克里斯皮尔生物技术公司 | 工程化核酸酶、组合物及其使用方法 |
| CN121127598A (zh) * | 2023-03-16 | 2025-12-12 | 埃皮克里斯皮尔生物技术公司 | 用于调控异常基因表达的系统和方法 |
| CN119955797B (zh) * | 2025-01-13 | 2026-01-23 | 江南大学 | Kif5b基因在调控成肌细胞生理活性中的功能和应用 |
| CN119954926B (zh) * | 2025-03-11 | 2025-10-28 | 华南农业大学 | Klf5转录因子在调控猪骨骼肌发育中的应用及方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190127713A1 (en) * | 2016-04-13 | 2019-05-02 | Duke University | Crispr/cas9-based repressors for silencing gene targets in vivo and methods of use |
| EP3515506B1 (en) * | 2016-09-23 | 2023-09-13 | University of Massachusetts | Silencing of dux4 by recombinant gene editing complexes |
| EP3906308A1 (en) * | 2018-12-31 | 2021-11-10 | Research Institute at Nationwide Children's Hospital | Dux4 rna silencing using rna targeting crispr-cas13b |
| WO2022133062A1 (en) * | 2020-12-16 | 2022-06-23 | Epicrispr Biotechnologies, Inc. | Systems and methods for engineering characteristics of a cell |
-
2022
- 2022-06-16 WO PCT/US2022/033797 patent/WO2022266324A1/en not_active Ceased
- 2022-06-16 AU AU2022293494A patent/AU2022293494A1/en active Pending
- 2022-06-16 KR KR1020247001784A patent/KR20240032038A/ko active Pending
- 2022-06-16 GB GB2319324.6A patent/GB2624791A/en active Pending
- 2022-06-16 EP EP22825819.0A patent/EP4355357A4/en active Pending
- 2022-06-16 JP JP2023577861A patent/JP2024523394A/ja active Pending
- 2022-06-16 MX MX2023014750A patent/MX2023014750A/es unknown
- 2022-06-16 CN CN202280056393.0A patent/CN117940150A/zh active Pending
- 2022-06-16 IL IL309174A patent/IL309174A/en unknown
- 2022-06-16 CA CA3221874A patent/CA3221874A1/en active Pending
-
2023
- 2023-12-15 US US18/542,396 patent/US20240216482A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024523394A5 (https=) | ||
| CA3042358C (en) | Zinc fingers and related adenovirus-associated virus vectors for the treatment of polyglutamine diseases, such as Huntington's disease | |
| KR20240011120A (ko) | 후성유전학적 편집을 위한 조성물 및 방법 | |
| JP2023552374A5 (https=) | ||
| US20220127621A1 (en) | Fusion proteins and fusion ribonucleic acids for tracking and manipulating cellular rna | |
| JP7069426B2 (ja) | ユートロフィン遺伝子を標的とした筋ジストロフィーの治療方法 | |
| JP2024520528A5 (https=) | ||
| JP2023544683A5 (https=) | ||
| FI4211231T3 (fi) | Peptidimodifioitu aav-kapsidi | |
| JP2021520203A5 (https=) | ||
| JP2021526858A5 (https=) | ||
| JP2020508685A5 (https=) | ||
| JP2023518541A5 (https=) | ||
| RU2018101710A (ru) | Мутации фермента crispr, уменьшающие нецелевые эффекты | |
| RU2019103691A (ru) | Искусственно сконструированная система регуляции ангиогенеза | |
| GB2624791A (en) | Systems and methods for regulating aberrant gene expressions | |
| JP2022507402A (ja) | 肝特異的ウイルスプロモーター及びその使用方法 | |
| WO2020069339A8 (en) | Mutant reverse tetracycline transactivators for expression of genes | |
| CN119013310A (zh) | 具有改善的编辑精确度的突变的胞嘧啶脱氨酶 | |
| RU2022105597A (ru) | Искусственно созданная система управления функцией шк | |
| JP2020533411A5 (https=) | ||
| JP2023543154A5 (https=) | ||
| JP2025521581A (ja) | エピジェネティック編集用の組成物および方法 | |
| JP2024522764A5 (https=) | ||
| JP2024515827A5 (https=) |